Stockscreener 앱 받기
0.6562
1.28%
-0.0085
시간 외 거래:
.66
0.0038
+0.58%
전일 마감가:
$0.6647
열려 있는:
$0.68
하루 거래량:
3.02M
Relative Volume:
0.30
시가총액:
$176.94M
수익:
$2.02M
순이익/손실:
$-97.59M
주가수익비율:
-1.1418
EPS:
-0.5747
순현금흐름:
$-102.38M
1주 성능:
-5.06%
1개월 성능:
-29.01%
6개월 성능:
-35.67%
1년 성능:
-71.84%
1일 변동 폭
$0.635
$0.68
1주일 범위
$0.635
$0.727
52주 변동 폭
$0.5469
$2.82
Humacyte Inc Stock (HUMA) Company Profile
명칭
Humacyte Inc
전화
919-313-9633
주소
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Compare HUMA vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
0.6562 | 179.23M | 2.02M | -97.59M | -102.38M | -0.5747 |
VRTX
Vertex Pharmaceuticals Inc
|
480.50 | 123.26B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.15 | 70.94B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.19 | 53.84B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
180.39 | 39.58B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
272.67 | 35.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-27 | 개시 | Barclays | Overweight |
| 2025-05-14 | 재개 | H.C. Wainwright | Buy |
| 2024-12-20 | 재확인 | H.C. Wainwright | Buy |
| 2023-12-11 | 개시 | H.C. Wainwright | Buy |
| 2023-08-14 | 업그레이드 | Piper Sandler | Underweight → Neutral |
| 2023-06-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-05-16 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2021-10-29 | 개시 | Cowen | Outperform |
| 2021-09-24 | 개시 | Oppenheimer | Outperform |
| 2021-09-22 | 개시 | BTIG Research | Buy |
| 2021-09-16 | 개시 | Piper Sandler | Overweight |
모두보기
Humacyte Inc 주식(HUMA)의 최신 뉴스
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Enterprise value to EBIT forward of Humacyte, Inc. – NASDAQ:HUMAW - TradingView
Investor Notice: Robbins LLP Informs Stockholders of the Class A - GuruFocus
Humacyte, Inc. (HUMA) beats stock market upswing: What investors need to know - MSN
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Humacyte appoints two nephrologists as commercial advisors By Investing.com - Investing.com South Africa
Humacyte appoints two nephrologists as commercial advisors - Investing.com
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access - The Manila Times
Form 13D/A HUMACYTE For: 13 July By Investing.com - Investing.com Nigeria
Fresenius to sell 5M Humacyte (HUMA) shares under Rule 10b5-1 plan - Stock Titan
Humacyte Inc (HUMA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Humacyte, Inc. (HUMA) stock sinks as market gains: Here's why - MSN
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
HUMAHumacyte Inc Options - Finviz
HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securitie - GuruFocus
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Enterprise value to revenue forward of Humacyte, Inc. – NASDAQ:HUMAW - TradingView
Humacyte, Inc. Warrant 2021-27.08.26 on Humacyte Financial Disclosures & SEC Filings - TradingView
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Humacyte Announces $50 Million Public Offering of Common Stock - Global Legal Chronicle
HUMA stock plunges after-hours on proposed share offering even as dialysis data impresses - MSN
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market - MSN
Enterprise value to revenue forward of Humacyte, Inc. – NASDAQ:HUMA - TradingView
Price to earnings forward of Humacyte, Inc. – NASDAQ:HUMA - TradingView
Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data - Yahoo Finance
Price to earnings forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Humacyte, Inc. (HUMA) latest stock news and headlines - Yahoo Finance Singapore
Price to book forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Price to sales forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Enterprise value to revenue forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Humacyte, Inc. Actuals & Estimates (NASDAQ:HUMA) - TradingView
Enterprise value to EBITDA forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Enterprise value to EBIT forward of Humacyte, Inc. – BOATS:HUMA - TradingView
HUMA Forecast — Price Target — Prediction for 2027 - TradingView
Humacyte Inc (HUMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
Form 13G Humacyte For: 22 June By Investing.com - Investing.com South Africa
Davidson Kempner reports 4.74% stake in Humacyte (NASDAQ: HUMA) - Stock Titan
Brokers Suggest Investing in Humacyte, Inc. (HUMA): Read This Before Placing a Bet - Yahoo Finance
Humacyte, Inc. (HUMA) dips more than broader market: What you should know - MSN
Piper Sandler Maintains Humacyte(HUMA.US) With Hold Rating, Maintains Target Price $1 - Moomoo
Humacyte Inc (HUMAW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Qiagen (QGEN) - The Globe and Mail
Humacyte Inc (HUMAW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Humacyte Inc (HUMA) Institutional Confidence - TradingKey
Humacyte Inc (HUMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Humacyte Inc (HUMA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Humacyte Inc (HUMA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Humacyte Inc (HUMAW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Humacyte Inc (HUMAW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Humacyte Inc (HUMAW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Humacyte Inc (HUMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.74%
3.77%
자본화:
|
볼륨(24시간):